Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Candida species are the fourth most common cause of hospital-acquired bloodstream infections (BSI) in the United States (5, 9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
In the citing paper
“These species proportions are very similar to those previously reported from the northeastern United States (9).”
In the citing paper
“The National Epidemiology of Mycoses Survey study demonstrated geographic variations in species distributions throughout the United States, with C. albicans ranging from 46% in the northeast to 70% in the southwest and C. glabrata ranging from 15% in the southwest to 26% in the northeast (9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 3×
“Nonetheless, prospective surveillance projects such as ours will allow rapid detection of such infections, which initially appeared in Japan [17, 18] and have been reported in the United States [19].”
BackgroundHiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00192-2 · Cited by 424 · cited 1×
“Several subprojects have evaluated samples of organisms from this study and have included validation measures, such as reidentification of species and retesting of antimicrobial susceptibilities in the Special Microbiology Laboratory at the University of Iowa College of Medicine [6–14].”
BackgroundSelf-citationPfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331
Self-citationCeftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United States
Burwen, D. R., Banerjee, S. N., Gaynes, R. P., & System, T. N. N. I. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1622 · Cited by 214
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Jones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00115-6 · Cited by 153
Self-citationMarshall, S. A., Wilke, W. W., Pfaller, M. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00212-5 · Cited by 146
Self-citationAntimicrobial Resistance: Issues and Options
(1998) · National Academies Press eBooks · doi:10.17226/6121 · Cited by 129
Cited by
Items 301–400 of 1,001
Li, F., & Palecek, S. P. (2008) · Microbiology · doi:10.1099/mic.0.2007/013789-0 · Cited by 88
Central Line–Associated Bloodstream Infections: Prevention and Management
Weber, D. J., & Rutala, W. A. (2011) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.11.012 · Cited by 88
Douglas, M. W., Lum, G., Roy, J., Fisher, D. A., Anstey, N. M., & Currie, B. J. (2004) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01269.x · Cited by 88
Doyle, T. C., Nawotka, K. A., Bellinger-Kawahara, C., Francis, K. P., & Contag, P. R. (2006) · Microbial Pathogenesis · doi:10.1016/j.micpath.2005.11.003 · Cited by 88
Wisplinghoff, H., Cornely, O. A., Moser, S., Bethe, U., Stützer, H., Salzberger, B., Fätkenheuer, G., & Seifert, H. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502158 · Cited by 88
Asynchronous Cell Cycle and Asymmetric Vacuolar Inheritance in True Hyphae of Candida albicans
Barelle, C. J., Bohula, E. A., Kron, S. J., Wessels, D., Soll, D. R., Schäfer, A., Brown, A. J. P., & Gow, N. A. R. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.3.398-410.2003 · Cited by 76
Sader, H. S., Watters, A. A., Fritsche, T. R., & Jones, R. N. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-29 · Cited by 87
Self-citationDaptomycin: A novel cyclic lipopeptide antimicrobial
Schriever, C. A., Fernández, C., Rodvold, K. A., & Danziger, L. H. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.11.1145 · Cited by 87
Lark, R. L., Chenoweth, C., Saint, S. K., Zemencuk, J. K., Lipsky, B. A., & Plorde, J. J. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00192-9 · Cited by 87
A multicenter evaluation of linezolid antimicrobial activity in North America
Ballow, C. H., Jones, R. N., & Biedenbach, D. J. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(01)00334-0 · Cited by 87
Self-citationCreaven, B. S., Egan, D. A., Karcz, D., Kavanagh, K. A., McCann, M., Mahon, M. F., Noble, A., Thati, B., & Walsh, M. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.04.010 · Cited by 86
Multicenter Evaluation of the New VITEK 2 Advanced Colorimetric Yeast Identification Card
Hata, D. J., Hall, L., Fothergill, A. W., Larone, D. H., & Wengenack, N. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01754-06 · Cited by 86
Logue, M. E., Wong, S., Wolfe, K. H., & Butler, G. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.6.1009-1017.2005 · Cited by 86
Azole Resistance in Candida glabrata
Whaley, S. G., & Rogers, P. D. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0554-5 · Cited by 85
Staphylococcus aureus bacteremia and endocarditis
Petti, C. A., & Fowler, V. G. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(01)00003-4 · Cited by 85
Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Finland
Salmenlinna, S., Lyytikäinen, O., Kotilainen, P., Scotford, R., Siren, E., & Vuopio‐Varkila, J. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050438 · Cited by 85
Ethanolamine Activates a Sensor Histidine Kinase Regulating Its Utilization in Enterococcus faecalis
Papa, M. F. D., & Perego, M. (2008) · Journal of Bacteriology · doi:10.1128/jb.00952-08 · Cited by 84
Moellering, R. C., Graybill, J. R., McGowan, J. E., & Corey, L. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.04.001 · Cited by 84
França, J. C. B., Ribeiro, C. E., & Queiroz‐Telles, F. (2008) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822008000100005 · Cited by 84
Mutnick, A. H., Biedenbach, D. J., & Jones, R. N. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00012-9 · Cited by 84
Self-citationChen, C., & Noble, S. M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002956 · Cited by 83
“Candida albicans is a ubiquitous component of the mammalian microbiome [1] as well as the most common fungal pathogen of humans [2,3,4,5].”
BackgroundPathogenic factors in Candida biofilm-related infectious diseases
Hirota, K., Yumoto, H., Sapaar, B., Matsuo, T., Ichikawa, T., & Miyake, Y. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13330 · Cited by 83
Mukherjee, P. K., Long, L. A., Kim, H., & Ghannoum, M. A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.07.030 · Cited by 83
Recognition ofCandida albicansby Mannan‐Binding Lectin In Vitro and In Vivo
Lillegard, J. B., Sim, R. B., Thorkildson, P., Gates‐Hollingsworth, M. A., & Kozel, T. R. (2006) · The Journal of Infectious Diseases · doi:10.1086/503804 · Cited by 83
Ahmed, S. H., Daef, E., Badary, M. S., Mahmoud, M. A., & Abd-Elsayed, A. A. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-76 · Cited by 82
Has the Epidemiology of Nosocomial Candidemia Changed?
Puzniak, L., Teutsch, S., Powderly, W., & Polish, L. (2004) · Infection Control & Hospital Epidemiology · doi:10.1086/502452 · Cited by 80
Surveillance studies: how can they help the management of infection?
Masterton, R. G. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.suppl_2.53 · Cited by 81
Lee, C., Chen, P.-Y., Huang, F., & Lin, C.-F. (2009) · PubMed · Cited by 81
AL-Hazmi, H. (2015) · Research and Reports in Urology · doi:10.2147/rru.s75419 · Cited by 81
Study of virulence factors in coagulase-negative staphylococci isolated from newborns
da Cunha, M. D. L. R. D. S., Rugolo, L. M. S. D. S., & Lopes, C. A. D. M. (2006) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762006000600014 · Cited by 81
Wong, M. T., Kauffman, C. A., Standiford, H. C., Linden, P., Fort, G. G., Fuchs, H. J., Porter, S. B., & Wenzel, R. P. (2001) · Clinical Infectious Diseases · doi:10.1086/322687 · Cited by 81
Self-citationCohen, Y., Vellozzi, E. M., & Rubin, L. G. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.898-901.2002 · Cited by 81
Staphylococcus aureusInfections and Antibiotic Resistance in Older Adults
Bradley, S. (2002) · Clinical Infectious Diseases · doi:10.1086/338150 · Cited by 80
Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers
Neely, M., Jafri, H. S., Seibel, N., Knapp, K., Adamson, P. C., Bradshaw, S. K., Strohmaier, K. M., Sun, P., Bi, S., Dockendorf, M. F., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01027-08 · Cited by 79
Sharma, N., Jandaik, S., & Kumar, S. (2016) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201620150713 · Cited by 80
Ren, D., Bedzyk, L. A., Setlow, P., Thomas, S. M., Ye, R. W., & Wood, T. K. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20053 · Cited by 80
Serological and Genetic Diversity of Capsular Polysaccharides in Enterococcus faecalis
Hufnagel, M., Hancock, L. E., Koch, S., Theilacker, C., Gilmore, M. S., & Hüebner, J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2548-2557.2004 · Cited by 80
Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent
Fulco, P. P., & Wenzel, R. P. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.6.939 · Cited by 79
Self-citationGlobal Antibiotic Resistance and Its Impact on the Dental Community
Pallasch, T. J. (2000) · Journal of the California Dental Association · doi:10.1080/19424396.2000.12223071 · Cited by 79
Drug delivery strategies for improved azole antifungal action
Yang, W. P., Wiederhold, N. P., & Williams, R. O. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802457188 · Cited by 79
Diekema, D. J., Pfaller, M. A., Turnidge, J. D., Verhoef, J., Bell, J. M., Fluit, A. C., Doern, G. V., Jones, R. N., & SENTRY PARTICIPANTS GROUP (2000) · Microbial Drug Resistance · doi:10.1089/mdr.2000.6.213 · Cited by 79
Self-citationDalle, F., Jouault, T., Trinel, P. A., Esnault, J., Mallet, J. M., d'Athis, P., Poulain, D., & Bonnin, A. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.7061-7068.2003 · Cited by 78
Li, J. Z., Willke, R. J., Rittenhouse, B., & Rybak, M. J. (2003) · Surgical Infections · doi:10.1089/109629603764655290 · Cited by 78
Marschall, J., Agniel, D. M., Fraser, V. J., Doherty, J., & Warren, D. K. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn104 · Cited by 78
Regulatory mechanisms controlling morphology and pathogenesis in Candida albicans
Kadosh, D. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.04.005 · Cited by 78
Glasmacher, A. G., Lilienfeld‐Toal, M. V., Schulte, S., Hahn, C., Schmidt‐Wolf, I. G. H., & Prentice, A. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01239.x · Cited by 78
The Exciting Future of Antifungal Therapy
Neely, M. N., & Ghannoum, M. A. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000395 · Cited by 78
Methicillin-Resistant Staphylococcus aureus: An Emerging Pathogen in Small Animals
Weese, J. S. (2005) · Journal of the American Animal Hospital Association · doi:10.5326/0410150 · Cited by 78
Jacobsen, M. D., Gow, N. A. R., Maiden, M. C. J., Shaw, D. J., & Odds, F. C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01549-06 · Cited by 77
Galectin-3 plays an important role in protection against disseminated candidiasis
Linden, J. R., De Paepe, M. E., Laforce-Nesbitt, S. S., & Bliss, J. M. (2013) · Medical Mycology · doi:10.3109/13693786.2013.770607 · Cited by 77
Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance
Kotey, F. C. N., Dayie, N. T. K. D., Tetteh‐Quarcoo, P. B., & Donkor, E. S. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211026927 · Cited by 77
New Insights into Chemistry and Anti-Infective Potential of Triazole Scaffold
Kharb, R., Yar, M. S., & Sharma, P. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391615 · Cited by 77
Zomorodian, K., Veisi, H., Mousavi, M., Ataabadi, M. S., Yazdanpanah, S., Bagheri, M. J., Mehr, A. P., Hemmati, S., & Veisi, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s161002 · Cited by 77
Antifungal activity of synthetic di(hetero)arylamines based on the benzo[b]thiophene moiety
Pinto, E., Queiroz, M. J. R. P., Vale-Silva, L. A., Oliveira, J. F., Begouin, A., Begouin, J., & Kirsch, G. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.042 · Cited by 77
ANTIFUNGAL SUSCEPTIBILITY TESTING
Pfaller, M. A., & Yu, W. L. (2001) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70192-6 · Cited by 77
Self-citationPfaller, M. A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.suppl_2.25 · Cited by 77
Self-citationInvasive Candidiasis: Turning Risk into a Practical Prevention Policy?
Sobel, J. D., & Rex, J. H. (2001) · Clinical Infectious Diseases · doi:10.1086/321812 · Cited by 77
Epidemiology of invasive fungal infections in neonates and children
Steinbach, W. J. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03288.x · Cited by 76
Abelson, J. A., Moore, T. B., Bruckner, D. A., Deville, J. G., & Nielsen, K. (2005) · PEDIATRICS · doi:10.1542/peds.2004-1605 · Cited by 76
Secreted Aspartic Proteases as Virulence Factors of Candida Species
Monod, M., & Zepelin, M. B. (2002) · Biological Chemistry · doi:10.1515/bc.2002.117 · Cited by 75
Polymicrobial bloodstream infections: Epidemiology and impact on mortality
Pavlaki, M., Poulakou, G., Drimousis, P. G., Adamis, G., Apostolidou, E., Gatselis, N., Kritselis, I., Mega, A., Mylona, V., Papatsoris, A., et al. (2013) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2013.06.005 · Cited by 75
Horvath, L. L., Hospenthal, D. R., Murray, C. K., & Dooley, D. P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4714-4717.2003 · Cited by 71
The role of nutrient regulation and the Gpa2 protein in the mating pheromone response of C. albicans
Bennett, R. J., & Johnson, A. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05367.x · Cited by 74
Bloodstream Infection: Differences Between Young‐Old, Old, and Old‐Old Patients
Gavazzi, G., Mallaret, M., Couturier, P., Iffenecker, A., & Franco, A. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50458.x · Cited by 65
Hsueh, P., Liu, Y.-C., Yang, D. I., Yan, J.-J., Wu, T.-L., Huang, W.-K., Wu, J.-J., Ko, W., Leu, H., Yu, C.-R., et al. (2001) · Microbial Drug Resistance · doi:10.1089/10766290152773383 · Cited by 74
Zeng, J., Teng, F., Weinstock, G. M., & Murray, B. E. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1149-1154.2004 · Cited by 73
Screening for MRSA: A Flawed Hospital Infection Control Intervention
Wenzel, R. P., Bearman, G. M., & Edmond, M. B. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/593120 · Cited by 73
Self-citationAquino, V. R., Lunardi, L. W., Goldani, L. Z., & Barth, A. L. (2005) · Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702005000500009 · Cited by 58
Carlisle, P. L., & Kadosh, D. (2010) · Eukaryotic Cell · doi:10.1128/ec.00046-10 · Cited by 73
Toenjes, K. A., Munsee, S. M., Ibrahim, A. S., Jeffrey, R., Edwards, J. E., & Johnson, D. I. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.963-972.2005 · Cited by 72
“The polymorphic yeast Candida albicans is the most common causative agent of systemic human fungal infections, and Candida species are the fourth most common cause of nosocomial septicemia (13).”
BackgroundSortino, M. A., Filho, V. C., Corrêa, R., & Zacchino, S. A. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.030 · Cited by 72
Bahare, R. S., Ganguly, S., Choowongkomon, K., & Seetaha, S. (2015) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-014-0086-1 · Cited by 72
Systemic Antifungal Therapy: New Options, New Challenges
Wong‐Beringer, A., & Kriengkauykiat, J. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.14.1441.31938 · Cited by 72
ANTISTAPHYLOCOCCAL (MSSA, MRSA, MSSE, MRSE) ANTIBIOTICS
Paradisi, F., Corti, G., & Messeri, D. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70302-3 · Cited by 72
Anatoliotaki, M., Valatas, V., Mantadakis, E., Apostolakou, H., Mavroudis, D., Georgoulias, V., Rolston, K. V. I., Kontoyiannis, D. P., Galanakis, E., & Samonis, G. (2004) · Infection · doi:10.1007/s15010-004-3049-5 · Cited by 71
DeRyke, C. A., Kuti, J. L., & Nicolau, D. P. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.333 · Cited by 71
Changing spectrum of invasive candidiasis and its therapeutic implications
Singh, N. (2001) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2001.tb00004.x · Cited by 71
Netea, M. G., Gijzen, K., Coolen, N. A., Verschueren, I., Figdor, C. G., van der Meer, J. W. M., Torensma, R., & Kullberg, B. J. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.05.013 · Cited by 71
Murray, M. P., Zinchuk, R., & Larone, D. H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.3.1210-1212.2005 · Cited by 71
Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults
Bow, E. J., Evans, G., Fuller, J., Laverdière, M., Rotstein, C., Rennie, R., Shafran, S. D., Sheppard, D., Carle, S., Phillips, P., et al. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/357076 · Cited by 70
Burnie, J., Matthews, R., Jiman-Fatami, A., Gottardello, P., Hodgetts, S., & D'arcy, S. (2000) · Clinical Infectious Diseases · doi:10.1086/314035 · Cited by 70
Bergamo, V. Z., Donato, R. K., Lana, D. F. D., Donato, K. J. Z., Ortega, G. G., Schrekker, H. S., & Fuentefría, A. M. (2014) · Letters in Applied Microbiology · doi:10.1111/lam.12338 · Cited by 70
Identification of Immunogenic and Serum Binding Proteins of Staphylococcus epidermidis
Sellman, B. R., Howell, A. P., Kelly-Boyd, C., & Baker, S. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6591-6600.2005 · Cited by 70
Dalle, F., Franco, N., Lopez, J., Vagner, O., Caillot, D., Chavanet, P., Cuisenier, B., Aho, S., Lizard, S., & Bonnin, A. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.12.4554-4559.2000 · Cited by 70
A Re-Evaluation of the Relationship between Morphology and Pathogenicity in Candida Species
Kadosh, D., & Mundodi, V. (2020) · Journal of Fungi · doi:10.3390/jof6010013 · Cited by 70
Pfaller, M. A., Acar, J. F., Jones, R. N., Verhoef, J., Turnidge, J. D., & Sader, H. S. (2001) · Clinical Infectious Diseases · doi:10.1086/320187 · Cited by 70
Self-citationOpal, S. M., Palardy, J. E., Parejo, N. A., & Creasey, A. A. (2001) · Critical Care Medicine · doi:10.1097/00003246-200101000-00003 · Cited by 70
Horn, D. L., Ostrosky-Zeichner, L., Morris, M. I., Ullmann, A. J., Wu, C., Buell, D. N., Kovanda, L. L., & Cornely, O. A. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0843-0 · Cited by 69
Burden of hospitalization of patients with Candida and Aspergillus infections in Australia
Slavin, M. A., Fastenau, J. M., Sukarom, I., Mavros, P., Crowley, S. J., & Gerth, W. C. (2003) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.05.001 · Cited by 69
de Perio, M. A., Yarnold, P. R., Warren, J. R., & Noskin, G. A. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/500000 · Cited by 69
Orbán-Gyapai, O., Liktor‐Busa, E., Kúsz, N., Stefkó, D., Urbán, E. Z., Hohmann, J., & Vasas, A. (2017) · Fitoterapia · doi:10.1016/j.fitote.2017.03.009 · Cited by 69
Schofield, D. A., Westwater, C., Warner, T., & Balish, E. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.015 · Cited by 55
Responses of Candida albicans to the human antimicrobial peptide LL-37
Tsai, P.-W., Cheng, Y.-L., Hsieh, W., & Lan, C. (2014) · The Journal of Microbiology · doi:10.1007/s12275-014-3630-2 · Cited by 68
RISK FACTORS FOR MORTALITY IN CHILDREN WITH CANDIDEMIA
Zaoutis, T. E., Coffin, S. E., Chu, J. H., Heydon, K. H., Zhao, H., Grow, H. M., & Walsh, T. J. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000172938.76561.8e · Cited by 68
Lasker, B. A., Butler, G., & Lott, T. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.750-759.2006 · Cited by 68
The Functional Basis of Mycophenolic Acid Resistance in Candida albicans IMP Dehydrogenase
Köhler, G. A., Gong, X., Bentink, S., Theiß, S., Pagani, G. M., Agabian, N. M., & Hedstrom, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409847200 · Cited by 67
Zhou, H., Wang, X., Li, Z., Kuang, Y., Mao, D., & Luo, Y. (2018) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.7b00571 · Cited by 67
Identification and Visualization of a Distinct Microbiome in Ocular Surface Conjunctival Tissue
Ozkan, J., Coroneo, M. T., Willcox, M. D. P., Wemheuer, B., & Thomas, T. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24651 · Cited by 67
Nosocomial Candidemia: An Ounce of Prevention Is Better Than a Pound of Cure
Diekema, D. J., & Pfaller, M. A. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502451 · Cited by 67
Self-citationLinezolid‐Induced Anemia and Thrombocytopenia
Waldrep, T. W., & Skiest, D. J. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.1.109.33504 · Cited by 67
Metadata
- Authors
- Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Wenzel, Richard P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 29
- Issue
- 2
- Pages
- 239-244
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157766752
- Cited by
- 1,387
- References
- 16
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 13 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 37 · 2018: 31 · 2017: 36 · 2016: 41 · 2015: 33 · 2014: 56 · 2013: 55 · 2012: 55
- FWCI
- 47.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- nosocomial bloodstream infection, hospital-acquired bacteremia, coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus, Gram-positive bacteria, Gram-negative bacteria, fungemia, methicillin resistance, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, Streptococcus viridans, neutropenia, intensive care unit, empirical antibiotic therapy, infection surveillance
- MeSH terms
- Candida, Cross Infection, Gram-Negative Bacteria, Gram-Positive Bacteria, Hospitals, Humans, Neutropenia, Staphylococcus, United States, Fungemia, Bacteremia, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.